Arcadia Investment Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Arcadia Investment Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-67	Closed	-$1K	–	298
2021 Q3	$1K	Hold	67	–	–	﹤0.01%	275
2021 Q2	$1K	Hold	67	–	–	﹤0.01%	290
2021 Q1	$2K	Buy	+67	New	+$3.04K	﹤0.01%	272
2020 Q4	–	Sell	-200	Closed	-$7K	–	284
2020 Q3	$7K	Hold	200	–	–	﹤0.01%	262
2020 Q2	$8K	Buy	+200	New	+$13.5K	﹤0.01%	251

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Arcadia Investment Management's EVFM Position: Q4 2021 in Review

Arcadia Investment Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2021, closing a stake of 67 shares — an estimated $1K sold.

Arcadia Investment Management first reported a position in EVFM in Q2 2020 and held it in 5 quarters. The position peaked at $8K in Q2 2020. 62 funds tracked by Wall St. Rank hold EVFM as of Q4 2021.

Arcadia Investment Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Arcadia Investment Management sold 67 Evofem Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $1K.
Arcadia Investment Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Arcadia Investment Management's Evofem Biosciences, Inc. Common Stock position peaked at $8K in Q2 2020.
62 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2021.

Based on Arcadia Investment Management's 13F filing for Q4 2021, filed 9 Feb 2022.